Press Releases

Health News Posted on Thursday, May 2, 2024

Premium Press Releases »

Outdated Perceptions and Practices Fuelling Mental Health Crisis, New Economist Impact Study Reveals

  International analysis of mental health provision in eight G20 countries reveals stigma, a shortage of mental health professionals and inconsistent availability and quality of care are creating barriers to vital mental health care services ...

Read More

Philips Successfully Prices Offering of Notes for Eur 700 Million to Be Used for Repayment of Existing Debt

May 23, 2024  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 700 million fixed rate notes due 2032 (the “Notes”) under ...

Read More

Bahrain Oncology Centre Amongst the First in the World to Offer Ground-breaking Sickle Cell and Transfusion Dependent Thalassemia Gene Therapy

MUHARRAQ, Bahrain, May 22, 2024 (GLOBE NEWSWIRE) -- The Bahrain Oncology Centre (BOC) has achieved a significant milestone, becoming amongst the first centres in the World to offer the ground-breaking CASGEVY (exagamglogene-autotemcel or ...

Read More

Press Releases »

Innosphere launches non-pharmaceutical ADHD clinical trial at top-tier research hospitals seeking pediatric patients

Evaluating safety and efficacy of Novostim 2 wearable device as key step towards future submission to FDA for marketing authorization  Patients can enroll at UTHealth in Houston Texas , and soon at Mayo Clinic in Minnesota , Boston ...

Read More

Recently Published Real-World Evidence Study Shows Effectiveness of Cell-Based Quadrivalent Influenza Vaccine Over Three Seasons

A real-world evidence (RWE) study recently published in Open Forum Infectious Diseases (OFID) examined three consecutive U.S. flu seasons in the United States . The study suggests that cell-based quadrivalent influenza vaccine (QIVc) may have ...

Read More

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference

STATEN ISLAND, N.Y. , May 2, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.